{"doi":"10.1093/infdis/jiae369","title":"Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial","abstract":"BACKGROUND: We evaluated the fully human polyclonal antibody product SAB-185 in a phase 3 trial for COVID-19. METHODS: Nonhospitalized high-risk adults within 7 days of symptom onset were randomized 1:1 to open-label SAB-185 3840 units/kg or casirivimab/imdevimab 1200 mg. Noninferiority comparison was undertaken for pre-Omicron population (casirivimab/imdevimab expected to be fully active) and superiority comparison for the Omicron population (casirivimab/imdevimab not expected to be active). Primary outcomes were the composite of all-cause hospitalizations/deaths and grade ≥3 treatment-emergent adverse events (TEAEs) through day 28. A secondary outcome was time to sustained symptom resolution. RESULTS: Enrollment ended early due to low hospitalization/death rates upon Omicron emergence; 255 adults were in pre-Omicron and 392 in Omicron populations. Hospitalizations/deaths occurred in 6 (5.0%) and 3 (2.2%) of pre-Omicron SAB-185 and casirivimab/imdevimab arms (absolute difference 2.7%; 95% confidence interval [CI], -2.3%-8.6%); and 5 (2.5%) versus 3 (1.5%) (absolute difference 1.0%; 95% CI, -2.3%-4.5%) for Omicron. All risk ratios for grade ≥3 TEAEs were not significant. Time to symptom resolution was significantly shorter for SAB-185 for Omicron only: 18 versus >25 days; P =.006. CONCLUSIONS: SAB-185 had an acceptable safety profile with faster symptom resolution in the Omicron population. CLINICAL TRIALS REGISTRATION: NCT04518410.","journal":"The Journal of Infectious Diseases","year":2024,"id":471452,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":1,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9621,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04518410"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":104974,"name":"Babafemi Taiwo","orcid":"0000-0003-2661-9103","position":1,"is_corresponding":false},{"id":419481,"name":"Carlee Moser","orcid":"0000-0001-5601-9112","position":2,"is_corresponding":false},{"id":351140,"name":"Eric S. Daar","orcid":"0000-0003-1880-7331","position":3,"is_corresponding":false},{"id":340150,"name":"David A. Wohl","orcid":"0000-0002-7764-0212","position":4,"is_corresponding":false},{"id":385130,"name":"Justin Ritz","orcid":"0000-0001-6307-4849","position":5,"is_corresponding":false},{"id":806068,"name":"Arzhang Cyrus Javan","orcid":null,"position":6,"is_corresponding":false},{"id":108340,"name":"Jonathan Z. Li","orcid":"0000-0001-9914-9662","position":7,"is_corresponding":false},{"id":109932,"name":"William A. Fischer","orcid":"0000-0002-4900-098X","position":8,"is_corresponding":false},{"id":108342,"name":"Alexander L. Greninger","orcid":"0000-0002-7443-0527","position":9,"is_corresponding":false},{"id":806014,"name":"Christoph Bausch","orcid":null,"position":10,"is_corresponding":false},{"id":806013,"name":"Thomas Luke","orcid":null,"position":11,"is_corresponding":false},{"id":1306668,"name":"Robert S. Call","orcid":null,"position":12,"is_corresponding":false},{"id":1067203,"name":"Gene Neytman","orcid":null,"position":13,"is_corresponding":false},{"id":387866,"name":"Mark J Giganti","orcid":"0000-0003-2255-9756","position":14,"is_corresponding":false},{"id":259563,"name":"Courtney V. Fletcher","orcid":"0000-0002-3703-7849","position":15,"is_corresponding":false},{"id":65752,"name":"Michael D. Hughes","orcid":"0000-0001-8562-2316","position":16,"is_corresponding":false},{"id":249713,"name":"Joseph J. Eron","orcid":"0000-0002-4938-0644","position":17,"is_corresponding":false},{"id":396976,"name":"Judith S. Currier","orcid":"0000-0003-4279-4737","position":18,"is_corresponding":false},{"id":36878,"name":"Davey M. Smith","orcid":"0000-0003-3603-1733","position":19,"is_corresponding":false},{"id":806070,"name":"for the ACTIV-2/A5401 Study Team","orcid":null,"position":20,"is_corresponding":false},{"id":863197,"name":"David R. Smith","orcid":"0000-0002-7330-4262","position":22,"is_corresponding":false},{"id":1041503,"name":"Michael S. Hughes","orcid":"0000-0002-3729-0350","position":28,"is_corresponding":false},{"id":610206,"name":"Lara Hosey","orcid":null,"position":32,"is_corresponding":false},{"id":863925,"name":"Jhoanna Roa","orcid":null,"position":33,"is_corresponding":false},{"id":863926,"name":"Nilam Patel","orcid":null,"position":34,"is_corresponding":false},{"id":863927,"name":"Kelly Colsh","orcid":null,"position":35,"is_corresponding":false},{"id":863928,"name":"Irene Rwakazina","orcid":null,"position":36,"is_corresponding":false},{"id":863929,"name":"Justine Beck","orcid":null,"position":37,"is_corresponding":false},{"id":333573,"name":"Scott F. Sieg","orcid":"0000-0002-1769-8682","position":38,"is_corresponding":false},{"id":751405,"name":"Jonathan Li","orcid":"0000-0002-8004-0015","position":39,"is_corresponding":false},{"id":571854,"name":"Teresa H. Evering","orcid":null,"position":42,"is_corresponding":false},{"id":74899,"name":"Rachel Bender Ignacio","orcid":"0000-0001-6167-1447","position":43,"is_corresponding":false},{"id":531919,"name":"Sandra Wagner Cardoso","orcid":"0000-0001-5230-0003","position":44,"is_corresponding":false},{"id":697926,"name":"Katya Corado","orcid":"0000-0003-2063-7925","position":45,"is_corresponding":false},{"id":233149,"name":"Prasanna Jagannathan","orcid":"0000-0001-6305-758X","position":46,"is_corresponding":false},{"id":218326,"name":"Nikolaus Jilg","orcid":"0000-0001-9154-2769","position":47,"is_corresponding":false},{"id":291274,"name":"Alan S. Perelson","orcid":"0000-0002-2455-0002","position":48,"is_corresponding":false},{"id":596958,"name":"Sandy Pillay","orcid":null,"position":49,"is_corresponding":false},{"id":596960,"name":"Cynthia Riviere","orcid":null,"position":50,"is_corresponding":false},{"id":233142,"name":"Upinder Singh","orcid":"0000-0003-0630-0306","position":51,"is_corresponding":false},{"id":633456,"name":"Joan Gottesman","orcid":null,"position":53,"is_corresponding":false},{"id":863930,"name":"Matthew Newell","orcid":null,"position":54,"is_corresponding":false},{"id":569135,"name":"Susan Pedersen","orcid":"0000-0002-7529-6876","position":55,"is_corresponding":false},{"id":261330,"name":"Joan Dragavon","orcid":null,"position":56,"is_corresponding":false},{"id":576178,"name":"Cheryl Jennings","orcid":"0009-0002-3508-5350","position":57,"is_corresponding":false},{"id":863931,"name":"Brian Greenfelder","orcid":null,"position":58,"is_corresponding":false},{"id":627346,"name":"William Murtaugh","orcid":null,"position":59,"is_corresponding":false},{"id":863932,"name":"Jan Kosmyna","orcid":null,"position":60,"is_corresponding":false},{"id":386408,"name":"Morgan Gapara","orcid":null,"position":61,"is_corresponding":false},{"id":327412,"name":"Akbar Shahkolahi","orcid":null,"position":62,"is_corresponding":false},{"id":315361,"name":"Kara W Chew","orcid":"0000-0003-4865-4348","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":null,"created_at":"2026-07-19T02:05:48.788780Z","pmid":"39028902","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}